NA Proactive news snapshot: Bioasis Technologies, Arizona Silver Exploration, Marvel Discovery, Algernon Pharmaceuticals, Ketamine One UPDATE … – Proactive Investors USA & Canada

A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires

Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) said results from an efficacy study of a blood-brain barrier penetrant interleukin-1 receptor inhibitor were successful in a preclinical rodent model of multiple sclerosis. Connecticut-based Bioasis is a pre-clinical, research-stage biopharmaceutical company developing a proprietary xB3 platform technology for the delivery of therapeutics across the blood-brain barrier (BBB), as well as the treatment of central nervous system (CNS) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. According to the company, a previously released work noted a recombinant fusion protein of Bioasis’ proprietary xB3 peptide with an interleukin-1 receptor antagonist (xB3-IL-1RA) demonstrated efficient delivery of effective concentrations of IL-1RA to the brain. The introduction elicited analgesia in a neuropathic pain animal model, while systemic administration of IL-1RA alone did not elicit analgesia. 

BioSig Technologies Inc (NASDAQ:BSGM) said it has completed its previously announced underwritten public offering of 2.5 million shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share. The gross proceeds to BioSig from this offering were $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig. The company said it intends to use the net proceeds from the offering for the continuation of full commercialization activities related to the PURE EP System, including additional support for organizational development, the continuation of its ongoing research and development activities for new products, and general corporate purposes and other capital expenditures. Laidlaw & Company (UK) Ltd acted as sole book-running manager for the offering. 

Arizona Silver Exploration Inc (CVE:AZS) (OTCMKTS:AZASF) said it had now received permits to drill up to 12 holes at its recently acquired Silverton project in Nye county, Nevada and is seeking to arrange roadwork and site preparation in late July ahead of the drilling. The explorer said it will announce the securing of a driller and a start date when arrangements are in place.

Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) has reached 70% of its enrollment target for its Phase 2 clinical study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough. The company said the purpose of the 20-patient proof-of-concept Phase 2 human trial is to determine the efficacy of Ifenprodil in the preservation of lung function (including biomarkers of fibrosis), as well as the reduction of associated chronic cough frequency in IPF patients.  As each individual patient enrolls in the study, Algernon said it will begin treatment on an immediate basis for a period of 12 weeks. There are six sites in total participating in the study with four located in Australia and two in New Zealand. 

Marvel Discovery Corp (CVE:MARV) (OTCQB:MARVF) has applied for full eligibility through the Depository Trust Company (DTC). The DTC is a subsidiary of the Depository Trust & Clearing Corp that manages the electronic clearing and settlement of publicly traded companies in the US. DTC eligibility will reduce costs and accelerate the settlement process for US investors and brokers enabling the company’s common shares to be traded through a much wider selection of brokerage firms through an electronic method of clearing securities.

Empress Royalty Corp (TSXV:EMPR)(OTCQB:EMPYF) has retained Venture Liquidity Providers Inc (VLP) to initiate market-making services to aid in maintaining an orderly trading market and improving the liquidity of Empress’ common shares. The market-making service will be undertaken by VLP through a registered broker WD Latimer Co Ltd, in compliance with the applicable policies of the TSX Venture Exchange and other applicable laws. For its services, Empress has agreed to pay VLP $5,000 per month for a period of three months. The agreement may be terminated at any time by the company or VLP. The company and VLP act at arms length, and VLP has no present interest, directly or indirectly, in the company or its securities. 

Ketamine One Capital Limited (NEO:MEDI) (OTCMKTS:KONEF) (FRA:MY0) has appointed Adam Deffett as its interim CEO. Deffett, who is also vice president of capital markets, will retain both positions as the company continues to consolidate medical clinics in an effort to become a North American leader in mental health treatments. As part of Ketamine’s updated strategy, the company changed its name from Myconic Capital, to Ketamine One in June.

LexaGene Holdings Inc (OTCQB:LXXGF) (CVE:LXG) has released its second-generation MiQLab Bacterial and AMR (Antibiotic/Antimicrobial Resistance) Panel, the company announced. The MiQLab sequel was expanded at the request of veterinarians to improve coverage for pathogens that cause other common types of infections, including skin, soft tissue, wound infections (SSTIs) and ear infections. Specifically, LexaGene’s Bacterial and AMR Test Version 2 (V2) screens for 10 pathogens and 35 genes and variants, that confer antimicrobial drug resistance.

IEC Electronics Corp (NASDAQ:IEC) announced that it has been awarded a multi-year contract, valued in excess of $45 million, from a Tier 2 Department of Defense contractor. The Newark, New York-based company said the award is a follow-on order extending IEC’s participation with a program it has supported for several years. In 2019 the contractor awarded IEC the entire outsourcing of this program associated with secured communications equipment for US aircraft, ground vehicles and surface warships. Investors responded well, sending shares nearly 5.6% higher to $10.80 in morning trade. 

Plurilock Security Inc (CVE:PLUR) (OTCQB:PLCKF) said it has secured a purchase order worth US$500,000 from a California state utility resource organization through a state-wide contract. Including the latest order, contracts signed by Plurilock since May 2021 represent a combined total of nearly US$3.81 million in sales. Plurilock said the newly secured purchase order is part of its continued efforts to secure larger contracts with organizations across different key industry verticals. For this new order, the company will provide the California state utility resource organization with the renewal of their Earthsoft EQuiS data management software licenses, as well as implementation and maintenance support. Plurilock also announced it has completed its US$1.15 million order with the US Department of the Navy.

Mindset Pharma Inc (CSE:MSET) (OTCQB:MSSTF) (FRA:9DF) revealed positive new study data on its psychedelic compound MSP-1014. The drug discovery company said MSP-1014 demonstrated “superior efficacy” and an improved safety profile compared to generic psilocybin in a head-to-head clinical trial. MSP-1014, Mindset’s first lead clinical candidate, is a differentiated next-generation psilocybin-based compound in the company’s Family 1 of novel psychedelics.

Gungnir Resources Inc (CVE:GUG) (OTCPINK:ASWRF) (FRA:AMO1) announces the discovery of an extensive induced polarization anomaly at its Knaften gold project in Sweden. The mining exploration company said it is now considering additional IP coverage and plans to incorporate new targets into its future exploration work plans, inclusive of drilling. Gungnir said the new IP anomaly of up to 30 millivolts per volt ( mV/V) measures about 1,200 metres (m) by at least 700m and is open to the north and south. It is located in an unexplored area within the southern half of a 4 x 5 kilometres (km) quartz diorite intrusion, entirely held by Gungnir, and about 3km southeast of the company’s disseminated-style Knaften 300 Gold Zone.

HempFusion Wellness Inc (TSE:CBD.U) (OTCQX:CBDHF) (FRA:8OO) said it has completed the previously announced acquisition of Sagely Enterprises Inc, a leader in premium CBD products with mass distribution in more than 14,000 retailers nationwide. Toronto-based HempFusion is a leading health and wellness company offering premium probiotic supplements and products containing CBD in 4,000 stores across 50 states.  The acquisition is the second such deal HempFusion has entered in the last three months. In May, HempFusion signed a definitive agreement to acquire pioneering CBD brand Apothecanna. 

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N) is set to bring in up to C$2.5 million from a private placing to expand the plant-based foods firm’s existing facilities and develop new products. In June this year, the company announced a deal with Australia’s Flexitarian Foods Pty Ltd, in which Naturally Splendid will become Flexitarian’s exclusive manufacturer of an extensive line of plant-based, meat-alternative products for the Canadian market. Under the placing, the company will issue up to 50 million units at C$0.05 each and each unit will comprise one Naturally Splendid common share and one-half of a share purchase warrant.

KWESST Micro Systems Chairman David Luxton gave an interview  (http://www.kereport.com/2021/07/06/KWESST-microsystems-a-review-of-the-product-lineup-for-this-defense-and-security-company/) to the Korelin Economics Report expanding on some of the key defense and security product lines and potential growth areas for the company. He started by reviewing the firm’s low energy cartridge system for use in military and policing applications, as well as the large market for individual consumer protection. He also outlined the interest from defense companies in their lineup of Fantom electric decoys, counter drone missiles, and laser defense product. Luxton also discussed the company’s Tactile Awareness Situation Control (TASC) military software platform, and its vast market potential.

Todos Medical Ltd (OTCQB:TOMDF) has appointed Ilanit Halperin corporate controller as the Israel-based company prepares for its next growth stage. A certified public accountant, the company said Halperin is the principal of Halperin Ilanit CPA and has over 25 years of financial reporting, accounting, and auditing experience. “We are very pleased to bring Ms Halperin on board to help strengthen the company’s financial controls as we embark on the next stage of growth for Todos,” said Todos CFO Daniel Hirsch in a statement. “Ilanit has made substantial progress in putting in place the financial infrastructure needed to successfully engage with the investment community going forward.”

Planet 13 Holdings Inc (CSE:PLTH) (OTCQX:PLNHF), a leading vertically integrated Nevada cannabis company, has added Moxie as the third store-in-store in its new Orange County SuperStore. The OC SuperStore in California opened on July 1. The other two store-in-store operations are Select and STIIIZY. “We are thrilled to add our third store-in-store partner to continue creating a differentiated and exceptional retail experience at our Orange County SuperStore,” said Bob Groesbeck, co-CEO of Planet 13, in a statement.

Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) (FRA:5U9) has appointed Amanda Galbraith to the board of directors to drive its communications strategy. A trusted advisor to political leaders, CEOs, board directors, and executive teams, the company said Galbraith is one of Canada’s foremost crisis communications and public affairs experts. Galbraith is currently a principal at Navigator, Canada’s leading high stakes public affairs firm, where she provides strategic counsel to private, public, and not-for-profit organizations, including those in the health, pharmaceutical, retail, finance, and technology sectors. Over the past 29 years, she has held senior communications roles with the Prime Minister of Canada and Mayor of Toronto and has also worked as a journalist. A regular media contributor, Galbraith is also the host of Free For All Friday, a weekly national radio show in the iHeartRadio talk network.

PlantX Life Inc (CSE:VEGA) (OTCQB:PLXTF) (FRA:WNT1) announced a new partnership with professional skier and ski film star Nick McNutt, who will become a PlantX Ambassador. McNutt, a well-known professional backcountry skier in British Columbia, will help broaden PlantX’s brand exposure in Squamish and the Canadian West Coast.

Major Precious Metals Corp (CSE:SIZE) (OTCMKTS:SIZYF) (FRA:3EZ) announced the completion of a non-brokered private placement of 24,285,715 company units, at a price of $0.35 per unit, for gross proceeds of C$8.5 million. The company said it intends to use the net proceeds from the private placement to support the large diamond drilling campaign already underway at its Skaergaard Project in eastern Greenland, with drilling expected to begin within the next few weeks. 

Mountain Valley MD Holdings Inc (CSE:MVMD) (OTCMKTS:MVMD) reported positive findings from tests using its Quicksome technology to store a polio vaccine, outside of the traditional cold chain system. The current system dictates that the vaccines, during transport and storage, must be preserved at a temperature range between plus 2°C and plus 8°C from the time the vaccine is produced until it is administered. The tests used Quicksome with the Trivalent Inactivated Poliovirus Vaccine (tIPV). It was left in a vial for five days exposed to 40°C and then reconstituted for injection at the point of administration. The Trivalent IPV is composed of three serotypes of inactivated polioviruses and IPV serotypes one and three achieved 50% preservation and stability, while IPV serotype two achieved 100% preservation and stability, said the company.

Pampa Metals Corporation (CSE:PM) (OTCQX:PMMCF) has officially uplisted to trade on the OTCQX Best Market effective today. The Canadian mining company with gold and copper projects in Chile, was graduated from the OTCQB Venture Market and will trade under the ticker symbol, OTCQX:PMMCF.  The OTCQX Market is designed for established, investor-focused American and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. 

Zynerba Pharmaceuticals Inc (NASDAQ ZYNE), a pharmaceutical company developing transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that CEO Armando Anido will present a company overview during the Ladenburg Thalmann Virtual Healthcare Conference at noon ET on Wednesday, July 14. Investors interested in arranging a virtual meeting with the Company’s management during the conference should contact the conference coordinator, the company said. 

Safe-T Group Ltd (NASDAQ:SFET) has reported that its second-quarter and first-half revenue increased by double-digits year-over-year, supported by strong organic growth alongside complementary strategic acquisitions. The company said it expects to report revenue for the quarter ended June 30, 2021, in the range of $1.62 million to $1.78 million, an increase of between 50% and 65%, compared to $1.08 million during the second quarter of 2020. On a preliminary basis, revenues for the six-month period ended June 30 are expected to be in the range between $2.97 million to $3.13 million, up from $2.16 million in the equivalent period of 2020. The figures do not include revenue from the recent acquisition of CyberKick Ltd, which is expected to contribute to consolidated revenue starting from the third quarter of 2021.

Elys Game Technology Corp (NASDAQ:ELYS) (NEO:ELYS) (FRA:3UW) announced that it has entered into a definitive purchase agreement to acquire Bookmakers Company US LLC, a Nevada-based sports betting company doing business under the name US Bookmaking (USB). Founded in 2016, USB provides sports wagering services such as design and consulting, turn-key sports wagering solutions and risk management. In exchange for a 100% interest, Elys will pay $12 million, half in cash and half in common shares. USB members will also have the chance to receive up to an additional $38 million, plus a potential 10 premium if certain milestones are hit over the next four years, the company said. The transaction is expected to close on July 15.

Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) and Neo Performance Materials Inc (TSE:NEO) have announced that the first of an expected 15 containers of mixed rare earth carbonate (RE carbonate) has been successfully produced by Energy Fuels at its White Mesa mill in Utah and is en route to Neo’s rare earth separations facility in Estonia, creating a new US-to-Europe rare earth supply chain. The first container holds approximately 20 tons of the product. More shipments of the rare earth carbonate are expected as Energy Fuels continues to process natural monazite sand ore mined in Georgia by Chemours (NYSE:CC) for both the rare earth elements and naturally occurring uranium that it contains. Energy Fuels and Neo also announced the signing of a definitive supply agreement by the companies’ respective affiliates. Under the agreement, Energy Fuels will ship all or a portion of its RE carbonate to Neo’s Silmet rare earth separations facility. Neo will then process Energy Fuels’ RE carbonate into separated rare earth materials for use in rare earth permanent magnets and other rare earth-based advanced materials.

Kodiak Copper Corp (CVE:KDK) (OTCMKTS:KDKCF) (FRA:5DD1) has unveiled encouraging first drill results from its MPD copper-gold project in British Columbia, which have underscored the potential for the property housing a major porphyry system. Notably, the work has expanded the 2019 Gate zone discovery six times to a strike length of around 800 metres (m) from 125m previously, while drilling also suggests that a 1.2 kilometre long copper-in soil target in the area is underlain by a ‘significant’ copper-gold-silver porphyry system.

Psyence Group Inc (CSE:PSYG) announced it is partnering with UK contract research organization Clerkenwell Health to pursue psychedelic palliative care trials. Toronto-based Psyence is developing clinical trials for palliative care patients who are facing a terminal diagnosis or persistent medical issue. Both Psyence and Clerkenwell will work together to design and deliver a clinical trial in the UK.

Idaho Champion Gold Mines Canada Inc (CSE:ITKO) (OTCMKTS:GLDRF) (FRA:1QB1) said it has commenced the planned drill program to test the large geophysical anomaly reported earlier this year at its 100%-controlled Champagne gold project in Idaho in the US. The company recently announced that it has signed a contract with National Drilling for an 8,000-metre exploration core drilling program. The drill and crew have mobilized to site and drilling is underway on the first hole. The drill program is designed to test the large induced polarization  anomaly with a series of drill holes. The first two drill holes will be placed on the recently acquired private ground located towards the west end of the IP anomaly. “Given the evidence uncovered so far on this huge anomaly, we have high expectations of encountering mineralization as we test the roots of the Champagne mineral system,”  President and CEO Jonathan Buick said in a statement.

Psyence Group Inc (CSE:PSYG) announced it is partnering with UK contract research organization Clerkenwell Health to pursue psychedelic palliative care trials. Toronto-based Psyence is developing clinical trials for palliative care patients who are facing a terminal diagnosis or persistent medical issue. Both Psyence and Clerkenwell will work together to design and deliver a clinical trial in the UK.

Phunware Inc (NASDAQ:PHUN) (FRA:2RJ) has announced that it will license its Smart Residential Solution to Regent Square, a premier mixed-use development in Houston, in partnership with GID and MKT Consulting. Founded over 60 years ago, Phunware said GID has developed or acquired over 86,000 residential units and 16.8 million square feet of commercial space. The properties consist of a wide spectrum of real estate, including multi-family rental properties, industrial, for-sale condominiums, retail, office, hotel, and parking. Regent Square is a master-planned community that combines a blend of 300,000 square feet (sq ft) of shops and restaurants with 200,000 sq ft of offices as well as 1,500 residences and 4,200 parking spaces.

American Manganese Inc (CVE:AMY) (OTCMKTS:AMYZF) (FRA:2AM) reports that the Rocher Deboule IP (induced polarization) geophysical crew will test “Vent Zone” iron oxide-copper-gold (IOCG) targets, with drilling expected to follow on the Rocher Deboule copper-gold property. The company said the Rocher Deboule deposit has had historic production of 36,457 tonnes containing 2,167,780 grams of silver, 133,676 grams of gold and 2,557,433 kilograms of copper between 1915 and 1929. It added that recent fieldwork involving rock and soil sampling of the western portion of the claims has revealed the potential for IOCG deposit types about 1-2 kilometers (km) west of the historic production.

American Eagle Gold Corp (CVE:AE) said it has identified potential Carlin-type drill targets at its Golden Gate property that are closer to the surface than initially believed. These new targets were discovered through the Controlled Source Audio Magnetotelluric (CSAMT) survey that was completed in May. The Nevada-based Golden Gate property is located on the Cortez Trend, which hosts three large Carlin-type gold deposits operated by Barrick Gold Corp (NYSE:GOLD) (TSE:ABX) (FRA:ABR) and Newmont Corporation’s (NYSE:NEM) (TSE:NGT) joint venture, Nevada Gold Mines.

Milestone Scientific Inc (NYSE:MLSS) has expanded sales of its equipment in Texas, saying that the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital has now begun using its CompuFlo Epidural Instrument. UTMB is a major academic health sciences center of global influence and the move comes after the MedTech group began selling CompuFlo disposables previously to the UTMB Health Galveston Campus Hospital.

Evergold Corp (CVE:EVER) (OTCMKTS:EVGUF) (FRA:5EG) revealed that drilling is now underway at its Golden Lion property, located in north-central British Columbia’s Toodoggone region. The company said greater than 2,000 metres (m) of core drilling is planned, focused on the GL1 Main Zone, where drilling in 2020 confirmed the presence of a broad, long, near-surface gold-silver zone, and a subsequent induced polarization survey identified a strengthening chargeability and resistivity response below last year’s drilling. Concurrent with the ongoing drilling, IP and soil and rock sampling coverage over the GL1 Main target is being expanded. To the east, mapping and sampling of several targets on the GL2 and GL3 target areas are also underway. Evergold said assay results will be reported when received, compiled and interpreted.

GR Silver Mining Ltd (CVE:GRSL) (OTCQB:GRLSF) (FRA:GPE) reported assay results from its Plomosas Silver Project in Mexico, which included 41.7 metres (m) of 1.13 grams per tonne (g/t) gold as well as 13.0m of 328 g/t silver, 1.2% zinc, and 0.1% copper. The company said the results, which represent wide intersections of predominantly gold and silver-rich epithermal veining, are from the final drill holes that will be incorporated into the resource estimation at the Plomosas Mine Area. 

Bragg Gaming Group (TSE:BRAG) (OTCMKTS:BRGGF) (FRA:SL4) announced that gaming industry veteran Chris Looney has joined the company as chief commercial officer. Looney previously held progressively senior roles at Microgaming, and prior to joining Bragg, worked as commercial director at Red Tiger Gaming, where he was instrumental in driving the company’s growth and success, Bragg noted. Looney will work closely with CEO Richard Carter to develop and execute on Bragg’s strategic vision for expansion in new regulated markets, including the growing US market. The company believes Looney’s addition will help advance its position in the North American B2B iGaming space.

Gungnir Resources Inc (CVE:GUG) (OTCPINK:ASWRF) (FRA:AMO1) announces the discovery of an extensive induced polarization (IP) anomaly at its Knaften gold project in Sweden. The mining exploration company said it is now considering additional IP coverage and plans to incorporate new targets into its future exploration work plans, inclusive of drilling. Gungnir said the size of the new IP anomaly indicates the potential for a larger area of mineralization on the new license. “The preliminary results from our IP survey are very encouraging, given that the new anomaly is situated within the same quartz diorite intrusion that hosts the Knaften 300 Gold Zone,” CEO Jari Paakki said in a statement.

Braxia Scientific Corp (CSE:BRAX) (OTC:BRAXF) (FRA:496), a company providing ketamine treatments for depression and related disorders, said it will participate in the upcoming Academic Industry Meeting Day (AIMday) on “Experimental Medicine in Psychiatry,” hosted by Oxford University on Wednesday, July 7. CEO Roger McIntyre will discuss with Oxford scientists how research will be conducted with ketamine and psychedelics that integrates machine-learning, proof-of-mechanism research and implementation science, which will be critical for the impact of any innovative psychedelic on population health. Intererested parties can lean more about the conference at https://bit.ly/3xl4BBf

American Battery Metals Corporation (OTCQB:ABML), a battery recycling technology and advanced extraction company, announced that CEO Doug Cole and CFO David Corsaut will participate in Alliance Global Partners’ Virtual Metals & Mining Conference on Tuesday, July 13.  AGP specializes in wealth management and the middle market institutional arena and prides itself on providing its clients with boutique-level services. To learn more about the event or to schedule a one-on-one meeting with American Battery management, interested parties can visit https://www.allianceg.com/events or email agpevents@allianceg.com or info@batterymetals.com.

CO2 GRO Inc (CVE:GROW) (OTCQB:BLONF) (FRA:4021)  announced that it will be exhibiting at Cultivate 21 in Columbus, Ohio with booths at the Hemp Conference on July 9th and 10th (booth 10), and the Horticulture Conference from July 11th to 13th (booth 2309). This is CO2 GRO ‘s first in-person conference since March 2020. Cultivate is known to attract more than 10,000 horticulture and hemp industry professionals and visitors from all 50 states and over 30 countries. More information on Cultivate 21 can be found at cultivateevent.org.